Post-onset inhibition of murine arthritis using combined chemokine antagonist therapy

Rheumatology

Volumn 43, Issue 1, 2004, Pages 39-42

  Gong, J H ^a   Yan, R ^a   Waterfield, J D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antagonists; Arthritis; Chemokines

Indexed keywords

ALANINE; ANTIINFLAMMATORY AGENT; CHEMOKINE; FAS LIGAND; FREUND ADJUVANT; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE EDEMA; ARTHRITIS; ARTICLE; CELL INFILTRATION; CHEMOTAXIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; INCIDENCE; JOINT; MALE; MEASUREMENT; MONITORING; MONOCYTE; MOUSE; MOUSE STRAIN; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; CHEMOKINE CCL2; CHEMOKINES; CHEMOTACTIC FACTORS; DRUG THERAPY, COMBINATION; FEMALE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JOINTS; MALE; MICE; MICE, MUTANT STRAINS; MODELS, ANIMAL; MONOCYTES; NEUTROPHILS; PEPTIDE FRAGMENTS;

EID: 0347093542     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg459     Document Type: Article

References (17)

1. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001;2:123-8.
2. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000;18:593-620.
3. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121-7.
4. von Andrian UH, Mackay CR, T-cell function and migration. Two sides of the same coin. N Engl J Med 2000;343:1020-34.
5. Rollins BJ. Chemokines. Blood 1997;90:909-28.
6. Murphy PM, Baggiolini M, Charo IF et al. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000;52:145-76.
7. Koch AE, Kunkel SL, Harlow LA et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992;90:772-9.
8. Peichl P, Ceska M, Effenberger G, Haberhauer G, Broell H, Lindley IJD. Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenetic role in rheumatoid arthritis. Scand J Immunol 1991;34:333-9.
9. Ratkay LG, Zhang L, Tonzetich J, Waterfield JD. Complete Freund's adjuvant induces an earlier and more severe arthritis in MRL-lpr mice. J Immunol 1993;151:5051-87.
10. Ratkay LG, Chowdhary RK, Neyndorff H, Levy JG, Waterfield JD. Treatment of experimental murine arthritis with transdermal photodynamic therapy. SPIE 1995;2371:596-600.
11. Gong JH, Ratkay LG, Waterfield JD, Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 1997;186:131-7.
12. 2-terminal residues. J Exp Med 1995;181:631-40.
13. Plater-Zyberk C, Hoogewert A, Proudfoot AE, Power CA, Wells TN. The effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 1997;57:117-20.
14. Mantovani A. The chemokine system; redundancy for robust outputs. Immunol Today 1999;20:254-7.
15. Baggiolini, M. Chemokines and leukocyte traffic. Nature 1998;392:565-8.
16. Mantovani A, Allavena P, Vecchi A, Sozzani S. Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses. Int J Clin Lab Res 1998;28:77-82.
17. Cook DN, Beck MA, Coffman TM et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 1995;269:1583-5.